Legislation – The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020
Changes to legislation:
There are currently no known outstanding effects for The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020, Section 33.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Amendment of Schedule 3033.
(1)
Schedule 30 M1 (particulars for advertisements to persons qualified to prescribe or supply) is amended as follows.
(2)
In paragraph 2, after “holder of” insert “
.
the temporary authorisation or
”
(3)
In paragraph 6, after “for the product” insert “
.
or, in the case of a product in relation to which there is in force an authorisation by the licensing authority on a temporary basis under regulation 174, the indications for the medicinal product consistent with the recommendation or requirement of the licensing authority as to the use of that product
”
(4)
In paragraph 7, after “product characteristics” insert “
.
, or in any equivalent summary published by the holder of a temporary authorisation,
”